These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1596693)
1. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Adamsson M; Fallgren B; Edvinsson L Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693 [TBL] [Abstract][Full Text] [Related]
2. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries. Adamsson M; Edvinsson L Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries. Edvinsson L; Adamsson M; Jansen I Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed. Ralevic V; Edvinsson L; Burnstock G Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403 [TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp. Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916 [TBL] [Abstract][Full Text] [Related]
6. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat. Sun XY; Edvinsson L; Hedner T J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380 [TBL] [Abstract][Full Text] [Related]
7. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. Bell D; Millar BC; McDermott BJ Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811 [TBL] [Abstract][Full Text] [Related]
8. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y. Schwieler JH; Hjemdahl P J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493 [TBL] [Abstract][Full Text] [Related]
9. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature. Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501 [TBL] [Abstract][Full Text] [Related]
10. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding. Heilig M; Edvinsson L; Wahlestedt C Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639 [TBL] [Abstract][Full Text] [Related]
11. D-myo-inositol 1,2,6-trisphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed. Donoso MV; Boric M; Prado M; Fournier A; St Pierre S; Edvinsson L; Huidobro-Toro JP Eur J Pharmacol; 1993 Aug; 240(1):93-7. PubMed ID: 8405129 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Edvinsson L; Ekblad E; Håkanson R; Wahlestedt C Br J Pharmacol; 1984 Oct; 83(2):519-25. PubMed ID: 6593107 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane. Fabi F; Argiolas L; Ruvolo G; del Basso P Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349 [TBL] [Abstract][Full Text] [Related]
14. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP). Wahlestedt C; Reis DJ; Yoo H; Adamsson M; Andersson D; Edvinsson L Neurosci Lett; 1992 Aug; 143(1-2):123-6. PubMed ID: 1436655 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate. Edvinsson L; Adamsson M J Cardiovasc Pharmacol; 1992 Sep; 20(3):466-72. PubMed ID: 1279294 [TBL] [Abstract][Full Text] [Related]
16. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation. Pernow J; Modin A; Lundberg JM Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494 [TBL] [Abstract][Full Text] [Related]
17. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission. Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147 [TBL] [Abstract][Full Text] [Related]
18. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy is associated with altered response to neuropeptide Y in uterine artery. Jovanovic S; Grbovic L; Jovanovic A Mol Hum Reprod; 2000 Apr; 6(4):352-60. PubMed ID: 10729318 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. Fallgren B; Arlock P; Edvinsson L J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]